| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 1,673,225 | 1,217,871 | 1,569,688 | 2,187,996 | | Cost of Revenue | 639,270 | 501,373 | (1,906,074) | 766,891 | | | Gross Profit | 1,033,955 | 716,498 | 3,475,762 | 1,421,105 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 630,375 | 527,164 | 3,196,609 | 661,850 | | Non Recurring |
-
|
-
| 17,305 | (17,305) | | Others | 43,555 | 41,727 | 42,298 | 37,908 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 360,025 | 147,607 | 219,550 | 738,652 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 17,305 |
-
| | Earnings Before Interest And Taxes | 360,025 | 147,607 | 236,855 | 738,652 | | Interest Expense | 20,354 | 17,830 | 11,855 | 15,423 | | Income Before Tax | 339,671 | 129,777 | 225,000 | 723,229 | | Income Tax Expense | 127,377 | 48,667 | 84,375 | 271,211 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 212,294 | 81,110 | 140,625 | 452,018 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 212,294 | 81,110 | 140,625 | 452,018 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $212,294 | $81,110 | $140,625 | $452,018 |
|
1.49% Nasdaq 
0.27%
Income Statement
